text:
Musicians of all stripes had the chance to audition Tuesday for the "MetroPerforms!" program, which places volunteer artists at stations around the transit system. One band that didn't bother to try out? I'm A Circle. The rockers' goal isn't really to entertain riders, but to warn them.
The first track off their debut EP is "Redline," an ode to the oldest of Metro's color-coded train routes. And the aggressive hook — "God damn you, Red Line /You really screwed me this time" — could easily have been written this week about the two computer malfunctions that shut down the entire Metro system on Saturday, or the separate issues that forced the closure of the Dupont Circle stop twice on Monday.
Inspiration actually came from an incident in October, says Dave Circle (all of the bandmates claim "Circle" is their last name). The 42-year-old bassist got stuck in a tunnel on his way to meet up with his girlfriend. "It seemed like forever. I was watching other people cursing, trying to use their phones. It was claustrophobic," he says. "I thought, 'This is a song.'"
His bandmates agreed. "They ride the Red Line and have had trials and tribulations," says Circle, who recently moved near Forest Glen. He grew up in the D.C. area and still remembers the thrill of taking the Metro with his dad on the day it opened. After being away in Las Vegas for four years, he came back to find out his beloved transit system wasn't quite the same. "It's not working anymore," he says.
That's all reflected in the tune, which Circle says mimics the feeling of his October Metro ride. "The song starts out in a rush. You're trying to get somewhere," he says. Suddenly, the insistent beat stops, making way for wailing guitar solos that signify the despair of a passenger unable to reach a destination. There's also a slight echo effect to evoke being stuck in a tunnel.
The lyrics don't resemble poetry as much as they do whiny tweets: "I got stuck on a train. I don't normally complain. But it was lame. Such a shame. Feel my pain." At least they're printable — unlike the name of a certain ditty by some Bloomingdale housemates who decided to call out Pepco's lousy customer service in a YouTube video. (Google "How hard can it be Pepco.")
The two songs seem to be forming the basis of a new artistic movement in Washington. It's not really protest music; it's complain music. And it's pretty darned catchy.
Hear "Redline"
You can hear I'm A Circle perform "Redline" live at Friday night's EP release party at Chief Ike's Mambo Room ($5, 8 p.m.; 1725 Columbia Road NW), or listen to a recording at Cdbaby.com/cd/imacircle.


text:
This content has been marked as final. Show 2 replies
1. Re: what is SQLDEVELOPER_CLOB_7orcldeveloper-Oracle Sep 19, 2012 2:37 PM (in response to 947771)As confirmed by SQLDeveloper development team, Here is some information on this:
When migrating SQL Server/Sybase IMAGES to Oracle in 'offline' mode, we cant upload the data using SQL Loader directly into the BLOB column because:
1. IMAGEs in SQL Server/Sybase dumped out in HEX.
2. Oracle s HEXTORAW function can only take 4000 chars
3. So data gets uploaded in chunks against the CLOB
4. Then a procedure is run with HEXTORAW to convert it to BLOB
5. After the data load is over, this additional CLOB column can be dropped from the table as Oracle allows you to drop a column.
All this happens in automated fashion for offline data load process. For On-line data move, this is not required.
Hope this helps
2. Re: what is SQLDEVELOPER_CLOB_7orcldeveloper-Oracle Sep 19, 2012 2:42 PM (in response to orcldeveloper-Oracle)You can read a blog entry on this topic here: http://dermotoneill.blogspot.com/2012/01/sybase-and-sql-server-image-data-move.html

subset: commoncrawl


text:
Happy Friday, everyone! Are you as pooped as I am? Last night I came home, contemplated unpacking my suitcase (still by the front door) but watched Project Runway instead. So it goes.
I've got a few headlines for you here, then I have more stuff coming up shortly:
- Some Coachella performers are stranded in the UK following a volcanic eruption in Iceland. The worst tragedy of all: Gary Numan might not make it!
- This piece is insanely long, but it brings up some interesting points: "The Tina Fey Backlash."
- Showtime is doing a version of the British series Shameless. You can watch episodes of the original show online. (Thanks, Zack.)
- James Mercer, Mason Jennings and Jack Johnson contribute music to 180 South, a flick about a man who retraces the 1968 journey of his heroes to Patagonia. Watch the trailer.
- Eminem is releasing a new album.
- Kick-Ass is hoping to dominate the box office (as it should).
- Here's a fun interview (and nice sneaker pic!) with Kick-Ass' Christopher Mintz-Plasse.
- USA has renewed Burn Notice for two more seasons.
- Patton Oswalt is no longer co-starring in that NBC comedy pilot, according to reports.
- Patton talks about his new Serenity comic in this Q&A.
- Here's a roundup of 18 good books coming out this summer.
- Real Time with Bill Maher has been renewed.
- From Weekend at Bernie's to Death at a Funeral, here's a list of comedies centered around dead bodies.
- Check out some pics of John Barrowman on Desperate Housewives.
- Dr. Steve Brule is taking your questions.
- Here are the best music videos based on movies.
- The Office's B.J. Novak once played Scattergories with Michael Jackson?
- I realize it's probably too early in the morning for this, but here's a helpful guide to understanding hyperspace.
- And this sweet '80s montage video has been around a little while, but I'm just seeing it now. (Thanks, Andres.)
Whitney has been writing about pop culture for USA TODAY since 1999, when Pop Candy began as a weekly column. Her interests include music festivals, mustaches, Lost, comic books and Andy Warhol. She lives in New York City. More about Whitney | E-mail Whitney


text:
Last week Story Landis, the interim chair of the National Health Institute's stem cell task force, testified before the U.S. Senate on President Bush's policy restricting federal funding of embryonic stem cell research. Landis opposes the current policy and declared that "science works best when scientists can pursue all avenues of research."
If the cure for Parkinson's disease or juvenile diabetes lay behind one of four doors, wouldn't you want the option to open all four doors at once instead of one door?
Landis' utilitarian view of ethics–the dominant view in the biomedical research community–seems to be some sort of "Monty Hall morality": If the potential for a cure lies behind any door, then we not only should open that path of research but should have the government fund it to the full satisfaction of the grant-writing researchers. Even if, like embryonic stem cell research, the potential for cures is more science fiction than science fact, we should throw open all doors – even if it means throwing obvious moral intuitions out the window.
Landis would, I presume, disagree with my moral qualms about killing human embryos since such entities are human beings but not human persons. Very well. Perhaps I should set aside my moral repugnance, follow the logical conclusion of this line of reasoning, and concede that we should follow all "avenues of research", including the one in which we harvest the organs of non-person clones.
If embryos (and certain fetuses) are not persons, and therefore are not entitled to either legal rights or moral concern, then we can use them in potentially creative ways. For example, in his forthcoming book, Defending Life: A Moral and Legal Case Against Abortion Choice, Francis Beckwith asks a question that logically follows from this view:
[W]hat would be wrong in a developmental biologist manipulating the development of an early embryo-clone in such a way that what results is an infant without higher brain functions, but whose healthy organs can be used for ordinary transplant purposes or for spare parts for the person from which the embryo was cloned?
For a supporter of abortion or embryo-destructive research* the only logically consistent conclusion is that there is nothing inherently immoral about creating human clones for spare parts. In fact, we could argue that we have a moral obligation to create organ-donating humans clones.**
Before this case can be made, though, we must deal with the counter-arguments that could be given against the position that the human clone has some sort of intrinsic dignity:
Counterclaim #1: It is morally wrong because the infant is entitled to her higher brain functions.
Response: As Beckwith notes, under this view the non-person infant cannot have rights (including entitlements) unless one has interests (and interests presuppose desires), and neither the pre-sentient fetus nor the resulting post-birth infant has interests (because she has no desires). Therefore, the infant could not arguably be harmed because of its lack of capacity for consciousness.
Counterclaim #2: Whether they are a "person" or not, it is morally wrong to kill a human being in order to harvest them for "spare parts."
Response: There are three responses that could be made to address this point:
(1) We are not necessarily talking about killing the cloned infant. In fact, it would likely be beneficial to keep the being alive since all of the parts will not necessarily be needed until hte being was fully developed.
(2) We already destroy human embryos (non-person humans) in order to harvest there parts and the morality of that action has not been conclusively settled.
(3) We harvest organs from humans that are "brain dead" so why should we not take them from beings that were never conscious?
Once we get past the emotion-based qualms against such a medically useful procedure, the justification for its implementation becomes self-evident. Some would even argue that we have a moral duty to create cloned infants (or grow them to the adolescent or adult stage of development) in order to harvest their organs. The utilitarian moral calculus is obvious: the organs would be beneficial to a "person" (the human patient) while doing no moral or legal harm to the non-sentient "donor" (the human clone).
Indeed, the justification for this position has been asserted ad nauseum in the embryonic stem cell debate so it hardly needs defending here. As is readily acknowledged by pro-choicers, only a moral monster would withhold such life-saving treatments for the sake of "non-persons." But we are not monsters. We are science-loving, cure-seeking Americans. That is why we should support—and have the Federal government fund—research for organ-donor clones.
*In reference to those who hold this view, Beckwith uses the term Anti-Equality Advocates (AEA). As he notes, "AEA is a term of art that refers to a particular sort of prochoice advocate, one that concedes substantial identity of the fetus to its post-natal self but nevertheless argues that intrinsic dignity is an accidental property acquired post-natally. Therefore, this particular sort of prochoice advocate denies that all human beings are equal (in the Lincolnian sense of equal before the law; or equal insofar as being moral persons)."
**For the sake of brevity, I've limited the discussion to the creation of human clones. Technically, the developmental biologist could manipulate the development of an early embryo that would otherwise be aborted in order to grow her (it?) to the point where the organs could be used for transplantation. Women could use their "choice" to choose to carry the newly disabled nonperson to term in order to sell it for spare parts. The abortion debate might even become moot if unwanted pregnancies could be turned into an entrepreneurial opportunity.


text:
Jodi Kantor, a reporter from the New York Times, talks to the editorial board about her meticulously researched book about U.S. President Barack Obama and First Lady Michelle Obama. She covered the Obamas during the 2008 presidential campaign and conducted hundreds of hours of interviews with more than 200 people for the book.
Q: What has been the reaction to the book?
I fact-checked the whole book so I was very surprised by the [negative]reaction from the White House last week. I think it was in part because there was definitely a tabloidization of the book. There was en embargo of the book and so people couldn't read it in advance. And that didn't stop them from opining on it on television, and really exaggerating it. For example, the Huffington Post described Michelle Obama and [chief of staff]Rahm Emanuel clashing in the hallway.. which is not what my reporting indicated at all. So the White House had an exceedingly harsh response.
And Michelle Obama goes on TV without having read the book and said the book tried to portray her as some kind of angry black woman. It's a mystery why she said that because she hasn't read the book. She is not portrayed that way but as a strong, impassioned woman.
Q: Why are people so focused on the First Lady?
Part of the confusion is nobody can even say whether First Lady-hood is a job or not. It comes with tremendous responsibilities but you can't get hired for it, you're not elected to it and you're not paid for it. So the nature of this role remains so undefined. It really is an empty vessel and every first lady has to find a way to make it meaningful.
First Ladies are incredibly influential in a way that is not really supposed to be acknowledged. We have stereotypes of First Ladies versus the reality. They often present a beaming image to the public. But in private they have a lot of steel in their spines. The role lags behind the real status of American women. A First Lady can never work or hold a paying job so she is never going to be up-to-date with the reality of what it means to be an American woman.
Q: What does the book reveal about managerial style?
Internal management has been a real issue in the presidency. This stems from fact that President is not an organization man and didn't have a lot of executive experience. And he was never really a believer in traditional hierarchies and really was an outsider. He brings in a group of advisers. And the cliche is not true that they are a tight, insular group of Chicago advisers. This group is not unified and there was a lot of tension and disagreement within this group about what sort of president he should be and how he should do things.
Q: Is there a certain elusive quality to the President?
He is so introverted and she is really clear about with aides about where she is on any given issue. And so in a way in my reporting I often felt there was a little bit of a Plato's Cave I had to look at the reflection, at Michelle Obama in order to see what was really happening. because the president himself is so hard to read. She is willing to be more vocal in her criticisms and tougher on his staff than he is. Hillary Clinton was not dissimilar.
Q: This is a person who wanted to bridge divides, yet it has been very difficult for him. How has power changed him?
Everybody truly does treat him differently now that he is president. He knows it and there is not that much he can do about it. There is a funny scene in the book with Brad Pitt. He comes to the Oval Office and he is pushing low-cost, environmentally sustainable housing in New Orleans... but even he is totally star-truck. The White House advisers couldn't understand why he was so quiet in the meeting. Even a guy as confident and famous as Brad Pitt becomes overwhelmed when he meets the President.
This is a guy who came to power based on a speech in 2004 in which he said there is no conflict between Red and Blue America. That is the podium on which his reputation and candidacy is built. By the end of book we are in the debt ceiling crisis. Things have become so polarized in Washington he can't get even in Republicans and Democrats to sit down and agree to a reasonable solution and has to capitulate to the Tea Party.Report Typo/Error
Follow us on Twitter: @GlobeDebate


text:
Current Share
Rates Effective
Rates Subject To Change Without Notice.
rates are subject to change without prior notice by the
TexStar Federal Credit Union Board of Directors.
Dividends are paid from current income and available earnings
after required transfers to reserves.
All Rates quoted are based on either monthly or quarterly
percentage rates.
The APY for share certificates assumes dividends are added back to the certificate.


text:
Synergy is a miniature ventricular support system that offers the potential of a new minimally invasive treatment option for patients with chronic heart failure who are not responding to standard medical care. The system's less invasive implant procedure is intended to reduce the surgical risks associated with implant procedures that require cardiopulmonary bypass support. In addition, Synergy is intended to reduce symptoms of heart failure and associated re-hospitalizations, as well as to improve exercise tolerance and quality of life. The Synergy system is comprised of CircuLite's proprietary Micro-pump, inflow cannula and outflow graft, a percutaneous lead that is connected to a wearable external controller and a lightweight, rechargeable dual battery pack system. Synergy's Micro-pump is the size of a AA battery, provides up to 4.25 liters of blood flow per minute, and is intended to reduce the heart's workload while improving blood flow to vital organs. Synergy supplements the heart's native pumping capacity and preserves its ability to respond to the patient's cardiac output demands. The system is surgically implanted using a mini-thoracotomy and the Micro-pump is placed in a pacemaker-like pocket.
- 1025 reads


text:
Nikolaj Coster-Waldau Talks Marriage & Divorce in Cosmopolitan April 2014
He's been with his gorgeous wife Nukaaku for almost 15 years, and now Nikolaj Coster-Waldau shares details about his exciting marriage in the April 2014 issue of Cosmopolitan magazine.
During his interview, the "Game of Thrones" hunk revealed his secrets to a happy marriage and his thoughts on divorce.
"You have to like each other - that's a good start," Mr. Coster-Waldau declared. "And of course, you have to stay physical together. But you also have to be able to laugh. if you can't have fun, then there's no point."
In regards his stand on divorce, Nikolaj stated, "I can't imagine life without my wife, but I don't think you should get a prize for staying together a long time. People grow apart."
"Divorce is always terrible, but I haven't met anyone who went through it and isn't happier now," he added.


text:
The Republicans on the House Energy and Commerce Committee have sent a letter to Environmental Protection Agency Director Lisa Jackson demanding information on an alleged secret "internal" email system the agency it uses in addition to the normal public one. The system is an alleged bid to escape federal transparency rules, including the Freedom of Information Act, regarding official communications.
The lawmakers, lead by Chairman Fred Upton, R-Mich., write:
In recent weeks, questions have been raised in Congress and among public interest groups about the use of one or more secondary email accounts and aliases by you and potentially other officials at the Environmental Protection Agency (EPA). Given your reported use of at least one alias email account in your conduct of agency business, we write to ask that you describe fully the nature and extent of this practice.
The inquiry is based on a claim in a new book by Chris Horner, a senior fellow at the free market Competitive Enterprise Institute and staunch critic of the EPA under President Obama. Horner claims he was told of the existence of the email system while working on his book The Liberal War on Transparency:
Horner said two former "fairly senior" EPA officials contacted him while he was researching his book, and gave him the name of one of the email alias names used by EPA Chief Jackson.
"Richard Windsor" was just "[o]ne of the alternate email addresses she used," according to Horner.
The GOP lawmakers' letter asks whether Horner's report is true, if that email account or other non-public ones are still in use, and what is the alternate system's purpose. A spokesman for the EPA could not be reached for comment.


text:
NSW independent MP
Releasing a draft private members bill to make the National Electricity Law an Act of the federal Parliament rather than state law, Mr Oakeshott said there was a clear conflict in states owning and regulating monopolies. The bill is an attempt to break the deadlock of proposed changes to electricity rules, which all states will need to agree to through the Council of Australian Government later this year. "The current National Electricity Law is a national law in name only – that has to change so that much fairer pricing rules can be implemented," he said. "Electricity prices are largely set under state-based rules for regulating electricity monopolies, and have increased massively with little or no compensation of consumers. States Governments have been the only winners." Network costs account for 60 per cent of retail electricity price rises.
The Australian Financial Review


text:
Denver, CO (SportsNetwork.com) - Ty Lawson poured in a team-high 23 points to go with seven rebounds and eight assists to help Denver secure its first win and hold off the Atlanta Hawks on Thursday.
Lawson banked home a three with 58.8 seconds left to put the Nuggets up 107-102.
The Hawks responded with a quick Jeff Teague jumper three seconds later to make it a three-point game.
Lawson then got tied up with Paul Millsap, and the Hawks controlled the tip. Millsap was fouled while attempting a close turnaround jumper, and converted on the subsequent free throws to pull Atlanta within 107-106 with just over 26 ticks remaining.
Atlanta was forced to foul Lawson, who missed the first free throw, but was able to convert the next for a 108-106 edge.
The Hawks went to Al Horford, who couldn't get his tough layup to go, but Millsap was fouled on the rebound.
Millsap's first free throw rimmed out, but he drained the second to cut it to 108-107 with just eight seconds left.
After a timeout advanced the ball past half court, the Hawks quickly fouled Nate Robinson, who sunk the first free throw, but missed his second to give Atlanta a chance to tie or win the game.
Millsap took the ball on the left block and fired a step-back jumper that rimmed out. Horford was there for the rebound, but couldn't get his shot to go at the buzzer and Denver held on for their first win of the season.
"I had a smaller guy on me so I figured I could shoot over the top of him," said Millsap. "I knew it would be difficult to get to the basket. I settled for my step-back jump shot. I felt like it was a good shot, it didn't go in."
Robinson scored 15 points off the bench while JaVale McGee and Randy Foye finished with 14 and 13 points, respectively, for the Nuggets, who shot 56 percent from beyond the arc (14-for-25).
"Nothing is going to be easy with this team, every night it's going to be a dog fight," Nuggets head coach Brian Shaw said. "We almost did everything in our power to not win it."
Millsap poured in a game-high 29 points to go with 10 rebounds and five assists and Horford finished with 21 points, nine rebounds and five assists for the Hawks, who have dropped two of their last three games.
After playing to a 26-26 deadlock over the first 12 minutes, the Nuggets were able to grab a 54-51 edge at the break.
Denver pushed their lead to 72-67 near the midway point of the third, but the Hawks shot their way back in it, and briefly took a 76-75 lead. The teams traded blows the rest of the way and went into the final frame tied at 83-83.
Game Notes
Lawson has scored at least 20 points in four straight games ... Denver avoided its first 0-4 start since 1998-99 ... The Nuggets had dropped their first two home games of the season after closing the 2012-13 campaign on a 23-game winning streak ... Hawks rookie Dennis Schroder served a one-game suspension for striking Kings center DeMarcus Cousins in the groin on Tuesday ... Kyle Korver scored 16 points on 6-of-10 shooting in the setback.


text:
That didn't take long. Just yesterday, Ned Lamont was the netroot hero, the pride of MoveOn.org, the scourge of the GOP. Today, Dem nomination in hand, he began his run toward the center - with a little help from his MSM friends.
On this evening's Hardball, Chris Matthews scoffed at the fact that the RNC put Lamont's picture up on its website alongside Michael Moore, Markos Moulitsas of the Daily Kos, Howard Dean, and John Murtha. Well, let's see: Dean via his DFA organization openly campaigned for Lamont over Lieberman. Daily Kos put itself totally in the service of Lamont. As for Moore and Murtha, can anyone point to an iota of difference between their views on Iraq and those of Lamont?
Would Matthews have scoffed had the RNC put up this actual photo showing Lamont on his victory platform surrounded by Jesse Jackson, Al Sharpton and NOW's Kim Gandy?
Interviewing Lamont, Matthews offered him the chance to show what a non-partisan guy he is, inviting him to name his Republican 'heroes.' Lamont mentioned Teddy Roosevelt - for busting trusts, Colin Powell, and John McCain - for being willing to buck the status quo.
An aside - Lamont noted that he disagreed with McCain on 'choice.' I don't know about you, but of all the political sleight of tongue, using 'choice' as a euphemism for abortion is one that particularly grates on me.
Later in the show, guest Howard Fineman did his bit. He claimed that Lamont gave "a very cogent answer" as to why Republicans should vote for him. Right. Lamont had made reference to the fact that he came from a business background. Just like George Soros and Jon Corzine, Howard. Lamont also said he wanted to help business by doing something about health care. Why do I have a sneaking suspicion that his solution would be something Hillary could love?
Fineman even went so far as to claim that Lamont "was really, basically a Republican most of his life as a town selectman in Greenwich." Right. Except for the fact that he was a Democrat.
In closing his interview of Lamont, Matthews said:
"I'll probably get in trouble for saying this, but I think it's great that people like you are running for office. Too many people own their seats in the Senate, own their seats in congress because they don't face formidable opponents like you. I'm glad you're running in this race, I can't support you, but people are better in this country for people in a race like this."
Can't support him, Chris? Don't be so modest. You just did!
Mark Finkelstein lives in the liberal haven of Ithaca, NY, where he hosts the award-winning public-access TV show 'Right Angle.' Contact Mark at firstname.lastname@example.com


text:
Docker is an open source framework that provides a lighter-weight type of virtualization, using Linux containers rather than virtual machines. Built on traditional Linux distributions such as Red Hat Enterprise Linux and Ubuntu, Docker lets you package applications and services as images that run in their own portable containers and can move between physical, virtual, and cloud foundations without requiring any modification. If you build a Docker image on an Ubuntu laptop or physical server, you can run it on any compatible Linux, anywhere.
In this way, Docker allows for a very high degree of application portability and agility, and it lends itself to highly scalable applications. However, the nature of Docker also leans toward running a single service or application per container, rather than a collection of processes, such as a LAMP stack. That is possible, but we will detail here the most common use, which is for a single process or service.
Thus, in this guide, we'll install the Apache Web server into a Docker container and investigate how Docker operates along the way.
Installing Docker
We'll use Ubuntu as the foundation of our Docker build. The Docker team itself uses Ubuntu for development, and Docker is supported on Ubuntu Server 12.04, 13.04, 13.10, and 14.04. The installation steps are slightly different for each version, so we will cover them all here.
From a fresh installation of Ubuntu 12.04, we will need to follow these steps to make sure we have the proper kernel version and associated headers:
$ sudo apt-get update
$ sudo apt-get install linux-image-generic-lts-raring linux-headers-generic-lts-raring
To continue reading this article register now
Learn More Existing Users Sign In


text:
There is major, major trouble in the focus and direction of the Romney Campaign in Boston. Remember, Mitt Romney's sole claim on the presidency was that he was the one person with the business experience to turn the economy around. The bet was that the slow economy would make the election a referendum on President Obama's economic stewardship. Well, the entire premise of his campaign has now come to bust, and they are now looking for a new argument:
Romney and — particularly — his running mate Rep. Paul Ryan, have spent a week road-testing alternatives, going positive and going negative, swinging at the president on everything from faith to foreign policy. The new efforts mark a shift from a summer of fruitless discipline and a convention in which attempts to present a friendly, moderate tone trumped any policy substance. And campaign planners said their moves mark a new campaign consensus.
Romney campaign, sputtering and leaderless, abandons economy as sole issue
Current Status: Blessed (1)
Seeded on Mon Sep 17, 2012 3:33 AM
keyboard shortcuts: V vote up article J next comment K previous comment


text:
COLLECTIBLE RESOURCESFind Collectible Buyers
Home Page
Collectibles Wanted
Wanted to Buy Ad
Collectible Articles
Register and Free NewsletterAntique Collector
WAS BARBIE PREGNANT?By Leon Carlson of Mister Find IT ®
Barbie collecting began in 1959 when that wonderful doll was introduced to us. Barbie, loved by so many, has been featured as the roll model of many American girls, "I want to be like Barbie". Every Barbie collector We've talked to has told us, "No, Mattel never made a pregnant Barbie doll". They did make the Heart Family. Production began in 1985 and ended in 1990. Mr. Heart was actually a "Ken doll" and Mrs. Heart looked like Barbie's cousin "Jazzie". It originally had a Mom, Dad and two twins. The collection soon included Grandpa and Grandma heart, six baby cousins, Trueheart the English sheep dog and all the accessories you could imagine. There are a lot of pregnant Barbie type dolls made by other companies, (Steffi Love, and Mommy to be Doll for example). But never a pregnant Barbie doll by Mattel! Mattel produced in 1986 a Heart Family "New Arrival Mom and Baby (#2412) that caught the attention of the media. Produced in both Caucasian and African American versions. I believe the #2412 was of the Heart Family, but it is not a Heart family doll that we're talking about, nor are we referring to Midge, Barbie's cousin. In the late 80's to early 90's, (possibly Barbie's 30th Birthday - during the Summer of the year) Mattel had announced they were going to release a pregnant Barbie to be sold in time for Christmas. Mattel had already started production of these Barbie's (I believe at their plant in Middleton, WI). Upon this announcement thousands of mothers protested to Mattel saying "We don't want our daughters growing up, to believe this is the way babies come about", "Barbie can't be pregnant - she hasn't even gotten married yet", etc., etc. and Mattel had stopped production and never officially released the doll. A friend whom we will call Sally, had a friend that worked at the plant. The friend at the plant sold Sally 3 of these pregnant Barbie dolls ($20.00 each), before production was stopped. The belly rolled around, (like smash up cars) concave on one side with a little baby that you lifted out. The other side bulged out, even after the baby was out. I have no idea how many of these dolls were stolen from the plant, (probably less then a dozen) but if they are out there you will find them between Middleton, WI and Minneapolis, MN. Now ironically a couple of years later Sally's house and dolls were destroyed by fire. In January of 2003 we were alerted to an e-bay auction that was titled "PREGNANT BARBIE~NOT MIDGE~SHE' HAVING A BABY" So we went there, and this was the description the seller gave: I CAN'T BELIEVE IT.........EVIDENTALLY BARBIE AND KEN GOT MARRIED SECRETLY BECAUSE SHE IS SPORTING A RING ON HER LEFT HAND AND IS READY TO HAVE A BABY ANY DAY....... JUST LIKE HER BEST FRIEND MIDGE FROM THE HAPPY FAMILY. BARBIE AND MIDGE LOOK SO CUTE TOGETHER WITH THEIR BIG TUMMIES. BARBIE COMES TO YOU LOOSE, DRESSED IN HER FAVORITE MATERNITY DRESS AND MARYJANE SHOES. BARBIE HAS A GENUINE BARBIE BODY. SHE HAS NOT BEEN PLAYED WITH AND IS IN GREAT CONDITION. HER PREGNANT TUMMY CAN BE REMOVED AND HER STOMACH WILL BE FLAT AGAIN FOR POST PREGNANCY GOOD LOOKS. SHE COMES WITH ROCKING CRIB FOR BABY, NEWBORN, BABY ACCESSORIES, RECEIVING BLANKETS. SHE IS LOOKING FORWARD TO MOTHERHOOD AND KNOWS KEN WILL BE A GOOD DAD! DOLL IS NOT PART OF THE HAPPY FAMILY. We would appreciate any updates on this pregnant Barbie, the two photos (1st two below) are from the above listing. The third photo is one we found in a March 2009, Google, image search from a site that no longer exists. The Blog said this was a Midge body, the side card says "Teen Pregnancy Barbie" but nowhere in the photo do we see the Mattel name. Can anyone tell us if this (1st two) is the #2412 Barbie, or if the last one is in fact by Mattel?
Note: Midge, Barbie's friend was being sold pregnant just before Christmas 2002, and many of the stores pulled them almost as fast as they were stocked. While doing this research we found that for Barbie's 40th Birthday, in 1999, a pregnant Japanese "Rika-Chan", (Japanese Barbie). was released. This article was originally published and is a copyright of Mister Find IT ® from our newsletter of August 2002, and edited February, November 2003, and again March 2009. See our last newsletter.
Click Barbie Doll for larger view.


text:
Is Linux the Future of Gaming?
Valve's managing director Gabe Newell recently made some extremely positive comments about Linux being the future of gaming.
Gabe Newell, the co-founder and managing director of Valve, said today that Linux is the future of gaming despite its current minuscule share of the market.
That seems hard to believe, given that Newell acknowledged Linux gaming generally accounts for less than one percent of the market by any measure including players, player minutes, and revenue. But Valve is going to do its best to make sure Linux becomes the future of gaming by extending its Steam distribution platform to hardware designed for living rooms.
Newell made his comments while delivering a keynote at LinuxCon in New Orleans. "It feels a little bit funny coming here and telling you guys that Linux and open source are the future of gaming," Newell said. "It's sort of like going to Rome and teaching Catholicism to the pope."More at Ars Technica
I'd love to know what Gabe Newell and Valve have up their sleeves. Newell is promising more information next week. So far Valve has done a fantastic job supporting Linux with Steam, so I'm hopeful that Newell isn't just engaging in hyperbole in his remarks.
Keep your fingers crossed, Linux gamers!
Download Firefox 24
Firefox 24 has been released for Linux, Windows and Mac. You can download it by going to the Firefox site, or just hit the Firefox FTP server.
Mozilla today officially launched Firefox 24 for Windows, Mac, Linux, and Android. Improvements include a new option to mass close tabs "to the right," as well as WebRTC support and NFC sharing on Android.
Here's the official changelog for Firefox 24:
NEW: Support for new scrollbar style in Mac OS X 10.7 and newer.
NEW: Implemented Close tabs to the right.
NEW: Social: Ability to tear-off chat windows to view separately by simply dragging them out.
CHANGED: Accessibility related improvements on using pinned tabs (see 577727).
CHANGED: Removed support for Revocation Lists feature (see 867465).
CHANGED: Performance improvements on New Tab Page loads (see 791670).
DEVELOPER: Major SVG rendering improvements around Image tiling and scaling (see 600207).
DEVELOPER: Improved and unified Browser console for enhanced debugging experience, replacing existing Error console.
DEVELOPER: Removed support for sherlock files that are loaded from application or profile directory.
FIXED: Replace fixed-ratio audio resampler in webrtc.org capture code with Speex resampler and eliminate pseudo-44000Hz rate (see 886886).More at The Next Web
I'm still on Firefox 23, so today looks like a great day to do an upgrade.


text:
Yeah www.facebook.com/stef.ormesher.9
Yeah www.facebook.com/stef.ormesher.9
Hey guys
Hope you don't mind me butting in! Have you booked hostels yet? Iv looked at a few but don't know what one to pick. Iv heard good things about base but looks like there is a few good ones.
I'm really worried about finding work too, I keep reading things saying its hard to come by and I was hoping to get some kind of work to stay out there longer. Have you guys had any luck?
Hi Kate,
No not looked at any hostels yet, didn't know whether to do hostel or hotel!? What kind of work are you wanting to do? I have been in touch with a couple of agencies that will meet me when I get there and then set me up with temp work.
When are you heading out?
I Land in sydney on the 1st of april and am planning on working there for a bit to save some money to go travelling have u all booked flights and hostels yet.
No not booked either yet, got my visa last weekend. Are you all sorted with a hostel??
i havent booked my hostel but am planning on starting at bounce in sydney when i get there i am flying from manchester were r u lot flying from
when r u thinking of going over to oz
Flying from Manchester too, looking at going 10th May. Need to get everything booked soonish.
What kind of work are looking at doing?
at the moment i work in accounts but i dont mind doing anything over there really waitressing or fruit picking i dont mind
Hey guys. like Carrie, im flying out on the 30th march to Sydney, Landing on the 1st. Already sorted a few nights in base backpackers which is meant to be fair oright. Got everything sorted, even my seats on the flight.haha. cant come soon enough now. Should hopefully already have a job when i get out there.


text:
News & Events
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs - Remarks at Generic Pharmaceutical Association
Remarks of Margaret A. Hamburg, M.D.
Commissioner of Food and Drugs
The Generic Pharmaceutical Association Annual Meeting
February 18, 2010
Naples, Florida
Thank you. I am very pleased to be here as part of your meeting—and grateful for a little respite from the cold and snow back home.
I appreciate the chance to be here today and your generous introduction and warm welcome. I have to say that in this role I am often a little uncertain about what kind of a welcome I will receive. This is not a job that always evokes warm feelings…though I have to say that I have been very heartened by the warm reception and welcomes I have received since my appointment as FDA Commissioner.
Beginning on the Hill as I made the rounds as part of the confirmation process, a place where certainly some FDA nominees have gotten frosty greetings, many Senators said the same thing to me: "Congratulations—and condolences. We have no idea why you'd want this job, but we're glad you do!"
Senator Mikulski made the most memorable comment when she said, "You're the daughter of a psychiatrist. Good. Because you're going to need all the mental health you can get." In fact, both my parents are psychiatrists, so I guess I am well-equipped…or, in fact, really crazy.
But I am really honored to be in this role, and very excited about the chance I have been given to work on issues that truly matter. In that regard, I am delighted for the opportunity to speak with all of you, the leaders of an industry that has come to play not only an important—but one of the most important—roles in the healthcare of Americans.
There are, of course, critical questions of policy and practice on all of our minds—questions of enforcement, biosimilars, user fees, and how my agency's attitude and approach to your industry might differ from that of recent years. I hope to at least touch on all these matters before our time together is up.
But first, I would like to speak more fundamentally about how the Generics industry and the FDA have much in common—more than it may often seem—including a unique opportunity and burden in this new decade to help each other better help the public's health.
I understand that when my colleague and Principal Deputy, Dr. Josh Sharfstein, spoke to your Policy gathering last year, he noted the accomplishments of your industry then but drew on words from the Spiderman comic series, to caution that "with great power comes great responsibility."
Josh may be more knowledgeable than I in the realm of comics, but I am sophisticated enough to know that the genesis of that quote is a bit more complex…some attribute it to Franklin Roosevelt…and some take it back to the Bible. But whatever the source, the sentiment is true, and I think it is a useful concept for us to contemplate…together. For it holds true for both our organizations and I want to focus on that.
Let us, though, first begin with a simple question that, as busy leaders and pressured decision-makers, we don't take the time to ponder often very often.
How did we get here?
Consider that 25 years ago for you, and about six times that for us, the Generics industry and the FDA were both nothing more than words on a piece of parchment in Washington. You were Public Law 98-417. We were Statute 12-387.
For us, those early years were rough. It was, believe it or not, the Great Emancipator, Abraham Lincoln himself, who created the Division of Chemistry that would evolve decades later into the Food and Drug Administration. But in 1862, that high-level support apparently didn't translate into much.
Our first offices were, and I quote, "of a dark subterranean character," where a "great dampness," accented by "acid fumes," prevailed. My early predecessor, whose salary was $1,500, had only resources enough to analyze a handful of grapes in his first study.
We've come a long way since those grapes. As the late Senator Edward Kennedy, one of our nation's greatest champions of public health, put it, the FDA has become the most important health agency in America. Some raise their eyebrows at that characterization…but I wholeheartedly agree.
Consider that the FDA regulates more than 1 in every 5 dollars of consumer spending in this country—food, drugs, medical devices, vaccines and biologics, cosmetics, dietary supplements, tobacco products, animal drugs, even some radiation-emitting products.
We are responsible for things people really care about and that matter for their health, safety and well-being. And even for things as mundane as the toothpaste we use in the morning, to that midnight snack we may sneak before bed—each of us is relying on the FDA, every day in so many ways. There's no escaping that.
A new era of responsibility and authority for the FDA began in 1938 when President Franklin Roosevelt signed the Food, Drug, and Cosmetic Act into law. This wasn't the occasion for which he wrote the words: "Great power involves great responsibility," but the words apply.
And the words apply to all of you. Your industry did not begin in "dark subterranean" offices, but, much like us, you grew from a debate on Capitol Hill…and now, of course, into a thriving industry.
Today, it is widely recognized that generic drugs are just as safe and effective as their brand-name counterparts. Your industry commands more than 75 percent of America's drug marketplace and saved consumers upwards of $750 billion over the past decade.
Clearly that means great power—and that, too, means great responsibility.
But responsibility can take many forms—to the bottom line, to our bosses and boards, to our investors. So let me clarify. While those are imperative responsibilities—ones we cannot and should not neglect—I am referring here to a distinctive responsibility that the FDA and the Generics Industry have uniquely in common.
We can remind ourselves of this responsibility when we ask not how we got here, as before, but WHY we got here.
The answer is simple. We were both created to better serve the public health. That is why Henry Waxman and Orrin Hatch worked tirelessly promoting your cause leading up to September 24, 1984, when the Hatch-Waxman Act creating the modern generic pharmaceutical industry was signed into law.
That is why another Roosevelt—Teddy—responded to Upton Sinclair's exposé of the food industry at the turn of the last century and actually created the official Food and Drug Administration through the Pure Food and Drug Act, a law that vowed to protect the public against "misbranded, or poisonous or deleterious foods, drugs, medicines, and liquors."
In other words, our duty to the public health is the necessary factor—the component without which we would not exist. And today, public health is the compass I try to use to steer the FDA through sometimes choppy waters.
Given my background as the New York City Health Commissioner, this is probably no surprise to you. But, partly for this reason, I was not the obvious pick for this position. In a gossipy town like Washington, it was actually humorous--though occasionally disturbing—that after being offered the job, accepting, going through vetting, but before my nomination was announced, I would read in the newspapers speculation about candidates for FDA Commissioner, and not see my name on the list.
But President Obama did not want to repeat the battles of past administrations—of nominating a pro-industry person who's attacked by consumer groups, or nominating a pro-consumer person who's attacked by industry groups.
I don't think you have to be either/or to be pro-public health. And that's what I am.
So what does this public health perspective really mean? The Institute of Medicine has defined the mission of public health as "fulfilling society's interest in assuring the conditions in which people can be healthy."
To be healthy, people need access to a safe and nutritious food supply and to the safest, most effective medical products possible. The FDA's role is to support this access and, in doing so, to promote health, prevent illness and prolong life.
Nearly two decades ago, when I first began my career in public health and accepted the position of New York City Health Commissioner, my great-aunt Winnie was baffled and upset by my decision. She complained to my father that she just couldn't understand why I would give up the opportunity to be a "real doctor."
My father tried to offer some consolation by telling her that I would still be a real doctor, but that instead of having one patient at a time, I would simply have eight million. Aunt Winnie didn't buy it—but I did. And now I guess I have more than 300 million patients.
But as you know, the public isn't so sure we are doing a very good job protecting our so-called "patients"... and no doubt that includes some of you. For much of our history, the FDA has been very popular. We used to rank at the top of government agencies in public opinion polls—second only to the National Park Service. Now we're down in the 30s—and sad to say, just ahead of the Internal Revenue Service.
When your job is protecting the people, and the people like you as much as they like the tax collector, they're sending a message that it's time to change.
So that is exactly what we're doing. We're putting public health first, and we're acting in a more agile and assertive way. Let me give you some examples.
In late 2008 there was an outbreak of salmonella related to peanuts. In fact, contaminated peanuts were detected by officials in Canada and returned to the US weeks before we knew of anyone getting sick. The FDA appropriately rejected the product at the border, calling it "unfit for food." But the agency did not trace the peanuts back to the plant. That happened only after people started getting sick.
The FDA reacted as a regulatory agency, not as a public health agency. The Agency made sure to meet a very strict regulatory timeframe and mode of action—which means that you wait for the epidemiology from the CDC, you make sure you're certain of everything, and then you go out with your action and your announcement.
Tragically, this proved to be one of the worst outbreaks. Eight people lost their lives, and nearly 20,000 got sick.
When President Obama came into office, the peanut outbreak was still resolving. He was first personally—and then as President—struck by just how important confidence in safety…in the products on the shelves and in our homes….really is. When he announced my appointment, he spoke to these issues and called for action.
The following month, in April, there was, in fact, another problem with nuts, this time pistachios. Kraft Foods alerted us that they had found salmonella in pistachios purchased from a company in California.
This time the agency did respond differently. We inspected the facility and found serious contamination. All this began before there were any confirmed cases of illness. Product was held, and we quickly put out a warning to consumers not to eat pistachios, but not yet to throw anything out.
We soon found the source of the contamination and narrowed the scope of our advice to the public. And we quickly helped the industry create a website that pointed consumers to products that were definitively not involved in the recall and were safe to eat.
Confidence was rapidly restored in both the product and the industry. The public did not panic, lives were not lost…nor were jobs. There were no huge costs to the industry. And this was certainly different than with peanuts. I think this was clear progress.
When, in another example of the new FDA, we issued a general warning to consumers about fraudulent products that claimed to diagnose, prevent, treat, or cure the H1N1 virus—and issued more than 5 dozen warning letters to offending websites—a trade press op-ed said, "FDA is taking extraordinary measures to protect the public from illegal H1N1 products…"
In the future, I hope FDA enforcement will be neither surprising nor extraordinary.
But my measure of success is not how many enforcement actions we've taken. Our goal is compliance, and enforcement is a path to compliance. We want to work with companies to help them comply with standards…and the majority do. But if companies do not, they need to have a realistic expectation that if they are crossing the line, we will act.
It's a change of approach. If FDA is too slow to recognize and respond to serious safety problems, then people are going to suffer unnecessarily…or even die preventable deaths. And our credibility will suffer…and it will deserve to suffer … and so will the credibility of industry.
We're going to act to protect the public. And in doing so, we'll improve trust and confidence in our work and that of the industry we regulate.
As the FDA and the generics industry recognize our shared mission, I believe there are a number of key ways we can—and must-- in fact, work together to more effectively respond to the public health threats and opportunities of our changing world.
First, I believe the FDA—and the generics industry—must try to better identify and prevent problems—to ensure quality—before problems occur. This is a basic tenet of public health, and a principle that must drive all of our work at FDA.
The principle of prevention is at the core of our Quality by Design program, which aims to build quality into each stage of the production process. We are asking not just how to fix problems….but how they can actually be prevented.
And we are reorienting our inspectors to focus on key measures for prevention, not just evidence of current problems.
But the world has gotten decidedly more complicated and so too have our jobs. We are feeling the challenge of globalization as I'm sure you are as well. When President Roosevelt created the modern FDA back in 1938, life was simpler. There were fewer facilities and many fewer imports. We were able to inspect more regularly—and with more certainty.
Today, FDA-regulated products are imported from more than 150 countries, with more than 130,000 importers and more than 300,000 foreign facilities.
The number of foreign registered drug manufacturers more than tripled over the past nine years. The number of drug products created at foreign sites has more than doubled since 2001. And the largest increase in drug manufacturing, as I suspect you know, has been in China and India, where there has been a huge ramp-up in FDA-registered drug manufacturers.
More countries than ever before are now part of the global supply chain, which means more factors and more barriers—barriers of language, geography, time, culture, facility information, and product history—that are largely out of our control.
Simultaneously, the supply chain from manufacturer to consumer has become more and more complex … involving a web of re-packagers and redistributors… and making oversight significantly more difficult.
This all adds up to an enormous task for the FDA…and we know that there are very real concerns. We all remember contaminated heparin vividly, and there have been many other problems as well. I was just reading a new report on the threat of counterfeit drugs which is growing worldwide.
Clearly we need a new paradigm for the 21st century.
We can never inspect our way to safety…that would mean hiring an army of tens, perhaps hundreds, of thousands of people to inspect foreign facilities and open every crate as it comes across the border. That simply won't work.
Instead, it means building up a worldwide network of oversight, working closely with other national governments and regulatory authorities, working with international organizations and others to harmonize standards and approaches, building regulatory capacity in other countries, developing third party certification systems, and sharing the responsibility of inspections and the information that comes from them.
But it also means—and I want to be clear here—that industry must also bear responsibility for the safety of the products in their supply chain, and not rely on the FDA to show up and find a problem. There are no free lunches, all parties must play a role—a proactive one—thinking both locally and globally to anticipate problems before even one human being is needlessly harmed.
The task of securing the international supply chain is a huge endeavor that will require fundamental and systemic change in the way we, and all of our trading partners, think about product safety.
It is a responsibility we share, and it's what we must do.
Second, we must do a better job developing the science that is the foundation of effective regulation.
When I started medical school, I was told that—with the advent of drugs and vaccines—the era of infectious diseases was basically over, and that the future of medicine was chronic disease. That was in the late 70s. Then we began to see the emergence of these strange cases of immune deficiency, mainly in previously healthy young men; nobody knew what the cause was and nobody even knew what to call it. I remember it was called GRID and 4H Syndrome…and then it was AIDS.
By the time I did my residency in New York City, I was taking care of a lot of AIDS patients. But there was nothing we could give them. There were no drugs available, only supportive care.
Later, I worked with Tony Fauci as assistant director of the National Institute of Allergy and Infectious Diseases. At that point in the AIDS epidemic, the great push was getting as many people as possible into the clinical trials, so they'd have at least some chance for treatment. But there were many people that were dying of AIDS that didn't qualify for the clinical trials and had no way to get drugs.
I was dealing every day with desperate people who wanted to live and had no hope.
Those were my early years in medicine, and they made me a passionate believer in the urgency of getting medical products to those who need them, and that success depends on teamwork; on the collaboration of scientists, pharmaceutical companies, advocates, and also the underappreciated midwife of drug development and approval: regulatory science.
Regulatory science is the science needed to evaluate, ensure and monitor a product's safety, effectiveness, potency, quality and performance. We need to advance this science to include new tools, methods, assays, standards, and models that will help speed the development, review, and approval of medical products.
Regulatory science may not be as sexy as discovery science…but it is really important and it really matters if we want to get products to people.
Let's start with biosimilars. As you know, there are a lot of concerns. How will we regulate these? Which framework will we use? These are important questions because patients want and need more access to these products—and, of course, I know how much promise they hold for your industry. Understandably, you're eager for answers.
First, we must develop a robust biosimilar approval pathway, which is more than what any short-term political patch can provide. After all, biosimilars raise questions for regulators that are far more complex than those posed by traditional generics.
For particular products, will we need clinical studies beyond bioequivalence? Is interchangeability possible? How will the approval process differ from the Biologic License Applications process?
We will address these questions as we work together over the coming months, which I look forward to, but I can say now that there will not be a 'one-size-fits-all' approach. There will, rather, be a science-driven, case-by-case decision-making process rooted in the regulatory studies that I would encourage your industry to support—as the FDA will—at this crucial time. The FDA can advance some of the science, but we can't do it all.
That may account for emerging generics, but what about the many existing generics? Even as we try our best to clarify to consumers that generics are safe, effective, and equivalent—and shortly after I became Commissioner, we revamped our website to dispel the myths about generics that persist—your industry can also work to better assess outcomes and act upon your findings.
Just as the FDA is beginning again to act aggressively and agilely in response to any credible report of impending problems, I ask that you, too, take public concerns seriously and rigorously investigate any potential therapeutic inequivalence. This too is a component of regulatory science.
I was encouraged to learn that some of you are, in fact, starting to support such studies examining these concerns. I believe you are making the right decision—for your bottom line, for your reputation, and above all, for your consumers.
Finally, let me mention that as we all know, no one benefits from a pending-application queue that will soon hit the 2,000 mark. This is simply unacceptable. Uncertainty and delays are costly to consumers, costly to you—and hurtful to the public. But the unprecedented spike in generics applications has simply outstripped our capacity to properly review, which must remain our foremost focus.
The solution lies in resources.
We have already begun to use the $10 million that Congress allotted to our agency to hire 50 additional scientists to address the generics-application backlog. But without action from your industry, too—without your support for a fair system of user fees—we simply cannot achieve for the public what we otherwise could. I know we have an essential part to play, too, in providing your industry with meaningful benchmarks...and in performing to those goals.
We very much want to work with you to see generic drug user fees enacted this year. Adequate and reasonable fees will be key to both more rapid review and to better surveillance. The merits of the former, I know are obvious to everyone in this room. But as I was just discussing, a robust inspectional presence is also critical to consumer confidence in safe and high-quality products.
And with the industry becoming ever more global, the continuing threat of intentional economic adulteration, and the increasing complexity of supply chains, we face tremendous challenges in our efforts to prevent or detect problems early – and user fees can assist us in meeting those challenges.
So I do hope we can return to the negotiating table soon.
Third, and finally, we must begin to better assess outcomes—to focus on quality after, not only before, the approval and release of products.
We are in the beginning of a new era for drug safety where protecting public health means that the FDA's responsibility doesn't end when we grant a product pre-market approval; that is merely the first check point in assuring safety.
Our responsibility extends for the entire time those products remain on the market. This life-cycle approach—as codified in the 2007 FDA Amendments Act —is a critical advance in public health protection. We are developing and honing the range of tools necessary to meet this important responsibility.
Post-marketing surveillance is key, but so is the ability of FDA require label changes to reflect new safety information, or to develop a Risk Evaluation and Mitigation Strategy, or REMS, for a particular drug. Medication guides, targeted outreach to health care professionals and pharmacists, or maybe even restrictions on who may prescribe the drug and under what circumstances an at-risk patient may take the drug is also important.
Last fall, we launched a Safe Use Initiative to encourage—in a broader way--that medications be used safely—meaning not accidentally ingested or overdosed… not given to patients who will not tolerate them… and not used inappropriately by patients at home.
Through this effort, we have partnered with a wide range of allies—from hospitals to health plans to pharmacies—and we will monitor our progress closely to be sure we are on the right track.
Just yesterday, FDA announced a new approach to confusion over the naming of over-the-counter drugs. We are discouraging companies from labeling different active ingredients with the same names – this confuses consumers and leads to avoidable, serious adverse events. Yesterday, with the support of FDA, one major company – the maker of Maalox -- is agreeing to rename some of its products to avoid confusion and better protect patients.
The generic industry is a critically important partner in our effort to encourage the safe use of medications. I know Dr. Sharfstein has challenged you to consider, for example, the serious problem of acetaminophen overdose. Many people take generic pain medication without recognizing that acetaminophen is a component. Then they take acetaminophen separately, and as a result, they may suffer serious liver injury.
These are significant concerns. If companies do not recognize that their business practices put patients at risk, and take action, then FDA will be forced to do so.
Together, we carry the sacred burden of safety. We must take this responsibility seriously.
So as I close, I want to reflect back on something my old boss President Clinton said back in 2000, when he spoke at the United Nations for the last time, to the largest-ever gathering of heads of state. He closed his remarks with these powerful words: "The leaders here assembled," he said, "can rewrite human history in the new millennium. But we must believe the simple things—that everywhere in every land, people in every nation, matter. Everyone counts, everyone has a role to play, and we all do better when we help each other."
I know that President Clinton was talking about a world far afield from the FDA or the generics industry at the time. But this morning, his message could not apply more.
The leaders here assembled can, and will, do better when we embrace the fact that everything—every factory, every ingredient, every product, every process, every consumer, every application—in fact matters.
And that a stronger FDA, one the public trusts as much as it once did, will translate into greater public confidence in your industry as providers of the safe, effective, equivalent, and affordable medicine on which so many have come to rely. In short, "we all do better when we help other."
In that spirit above all, I look forward to our discussion in the coming days, weeks, and months. But as President Lincoln, the patron saint of that dark, subterranean FDA precursor, once said, let us "leave nothing for tomorrow which can be done today."
Thank you.


text:
Ms. Jessica has been an instructor for the Dance Department over four
years and worked with all ages. Prior to teaching, she has taken ballet,
tap and jazz and many other types of dance styles over the span of 16
years. She had competed for 2 different studios and had received
recognition. In 2010, she and her group were awarded Grand Champions
of Starbound Competition in Lake Tahoe. She also participated in many
musical theatre shows with Star Struck Youth Theatre. Musicals like
42nd Street, Cats, The Music Man, Annie and Guys & Dolls.
Jessica's passion for dance flows when teaching. She enjoys spreading
her knowledge and sharing her experiences to others.
She hopes to see you in her class!
Cole Lorenzo
Dance Assistant Children & Youth Hip Hop
Cole had been dancing and training Hip-Hop since 2008 in a dance crew named re.DEFINE dance company, currently directed by Michael Mappala and co-directed
by Margela Cruz and Ron General.
Cole love to dance and teach dance. First is because dance is a good way for him to express his words and emotions through his choreography. He says it is fun and easy for everyone to understand especially to a dance community who is supportive. Second is because he
can spread his knowledge to other people and hope that they strive to love and have a passion for dance like the way he does.


text:
Agave Nut Butter
Apple Peanut Butter Cookies
Apple Pumpkin Brown Betty
Apple Spice Breakfast Soup
Apple Sunflower Sandwich Roll
Apricot Crumble Parfait
Apricot Lemon Cupcakes
artichoke and olive pizza
Asparagus Linguine with Almond Crisp
Baked Acorn Squash Rings
Baked Apple Streusel Pancake Bars
Baked Avocado Donuts
baked berries with pistachio cream
Baked Biscoff Donuts
Baked Blueberry Donuts
Baked Broccoli Burgers
Baked Chicken-less Taquitos
Baked Eggplant Burger
Baked Grapefruit Donuts
Baked Lemon Donuts with Strawberry Glaze and Coconut
Baked Polenta with Field Roast Italian Sausage
baked salt and vinegar potato wedges
Baked Stuffed Onions
Banana Cake with Coconut Cream Cheese Frosting
Banana Chocolate Chip Cake with Peanut Butter Frosting
banana pudding milkshake
Berry Chocolate Chip Granola
Black-Eyed Pea Dip
Blueberry Cornbread
Blueberry Muffins
Boston Cookies
Bourbon Caramel Popcorn
Bourbon Peach Cobbler
Bourbon Spice Cupcakes
bread and tomato soup
Broccoli and White Bean Salad
Brown Sugar Bars
Butter Pecan Cupcakes
buttermilk biscuit mac and cheese
butterscotch finger cakes
Cabbage Almond Smoothie
Caramel Apple Upside-Down Cornmeal Cake
Carrot Cake Donuts with Coconut Cream Cheese Frosting
Cherry and Plum Bruschetta with Sweet Cashew Ricotta
Cherry Chocolate Oatmeal Cookies
Cherry Cordial Brownies
Chestnut Cake with Maple Frosting
Chestnut Soup
Chicken-less Pot Pie Soup
chicken-less stuffed baked potatoes
Chipotle Cashew Cheese
Chocolate Carrot Cake
chocolate covered potato chips
Chocolate Dipped Marshmallow Brownies
Chocolate Gravy
Chocolate Maple Oatmeal Skillet Cookie
Chocolate Orange Cupcakes
Chocolate Potato Cake with Raspberry Buttercream Frosting
Chocolate-Covered Cherry Cookies
Cinnamon Sugar Cupcakes
Citrus Granola Parfait
Citrus Tea Punch
Coconut Cake with Chocolate Chunks
Coconut Dragon Bowl
Coconut Lime Berry Cake
Coconut Pineapple Loaf Cake
coffee cake cupcakes
coffee date pancakes with chocolate date butter
Cookie Brownies
Cranberry Pecan Sheet Cake
Creamy Polenta with Zucchini and Tomatoes
Creamy Strawberry Coconut Breeze
Curried Apricot Couscous
Double Layer Pineapple Upside Down Cake
Double Layer Pineapple Upside Down Cake
Dried Apple Stack Cake with Molasses Cream Cheese Frosting
Drop Biscuit Pear and Dried Cherry Cobbler
Drop Biscuit Pear and Dried Cherry Cobbler
Easy Nutter Butter Peanut Butter Ice Cream Pie
Fruity Peanut Butter Chia Breakfast Sandwich
fudgy pudding cake
Garlic and Yukon Gold Potato Soup
Ginger Candy
Gooey Chocolate Skillet Cake
green beans with sweet mustard vinaigrette
Hazelnut Chocolate Cupcakes
Homemade Ding Dongs
Hot Southern Greens with Sautéed Sweet Potatoes
Hummingbird Cupcakes
Indoor Peanut Butter S'mores
italian lentil sliders
jalapeno cornbread biscuits
Kettle Chip Crusted Buttermilk Tofu with Garlic Asparagus
Kettle Cookies
Lemon Speculoos Cupcakes
Lemony Lemon Cupcakes with Orange Sugar
Mac and Cheese Pizza
Maple Candy
Maple Cinnamon Applesauce
Maple Peanut Butter French Toast
maple sweet potato pecan burgers
Maple Walnut Cake
My Favorite Kale Salad
No Bake Chocolate Pretzel Peanut Butter Squares
Orange Shortbread Cookies
Peach and Blackberry Coffee Cake
Peach Cake
Peach Cobbler Drop Cookies
peanut butter coconut icebox pie
peanut butter popcorn cake
peanut butter popcorn fudge
Pear Cakes
plum streusel coffee cake
Potato Carrot Mash
Red Cabbage Sheet Cake
Red Velvet Cupcakes
Rhubarb Upside Down Cake
Roasted Cabbage with Warm Walnut Dressing
Roasted Red Pepper Mashed Potato Cakes
Salsa Verde Burgers with Avocado Mayo
Savory Molasses Biscuits
Seven Layer Dip with Cashew Sour Cream
Skillet Pear Gingerbread Cake
Sloppy Joe Sliders
Strawberry Milk Cupcakes
Strawberry Rhubarb Crisp Bars
Strawberry Walnut Bars
Sunken Grape Cupcakes
Sweet Potato Peanut Butter Blondies
Sweet Potato Tofu Pizza
Swiss Chard with Cashew Cream
tomato cucumber couscous salad
Vanilla Walnut Milk
Vegan Raspberry Butter
Veggie Tortilla Roll-ups
Vidalia Onion Mini Cornbread Muffins
Vidalia Onion Mini Cornbread Muffins
White Bean and Pasta Soup
White Chicken-less Chili
Bourbon Peach Cobbler
Bourbon Peach Cobbler
Recipe found at
6 cups of peeled and sliced peaches (canned or fresh)
1/4 cup bourbon
3/4 cups plus 1 tablespoon vegan refined sugar
2 tablespoons cornstarch
1 teaspoon cinnamon
1 1/4 cups all-purpose flour
2 teaspoons baking powder
1/2 teaspoon sea salt
12 tablespoons plus 2 tablespoons Earth Balance Natural Buttery Spread
2 tablespoons soy creamer
Vanilla dairy-free ice cream to top with (optional)
Directions for peeling peaches:
For the peaches, I used half fresh and half canned. If you want to use fresh peaches, there's an easy way to get the peel off. First, slice a small X into the bottom of the peaches.
Bring a pot of water to boil and blanch the peaches for at least 30 seconds. The less ripe the peaches are, the more time they'll need to boil.
Remove from heat and immediately submerge the peaches into ice water for one minute.
Remove from the water and peel. Ta-da!
Directions for making the cobbler:
To make the cobbler, preheat your oven to 375 degrees fahrenheit.
In a large bowl, stir together the peaches, bourbon, 1/4 cup of sugar, corn starch and cinnamon.
In a food processor, blend together the flour, 1/2 cup of sugar, baking powder, salt and 12 tablespoons of Earth Balance. Don't overdo it, the dough should be just a little bit sticky but not runny. If you don't have a food processor, you can mix these ingredients together by hand. I actually recommend using your bare hands to mush it all together.
Melt the last two tablespoons of Earth Balance over low heat in a 10-inch cast iron skillet.
Add in the peach mixture and cook until the peaches are warm, about 2 minutes for canned peaches and 5 minutes for fresh peaches.
Remove from heat and spoon the dough over top of the peaches.
Brush the top with your soy creamer and sprinkle with the remaining tablespoon of sugar.
Place the skillet in the oven and bake for 40 minutes, or until the top begins to brown and you can see the peaches bubbling underneath.
Serve warm with vanilla dairy-free ice cream, if that's your thing. It's definitely my thing.
Sign in
Recent Site Activity
Report Abuse
Print Page
Powered By
Google Sites


text:
Dinah Maria Mulock Craik
Dinah Maria Mulock Craik (20 April 1826 - 12 October 1887 / Stoke-on-Trent / England)
» Click to list general statistics » OR, select a date :
A Fable
SILENT and sunny was the way
Where Youth and I danced on together:
So winding and embowered o'er,
We could not see one rood before.
read more >>
- Hits: Number of visitors who read the poem on the given date.
- Posts: Number of visitors who posted the poem to a friend (via e-mail) on the given date.
- Dates that have "0" hits may not be shown on the list.
- Dates, poems and poets that have "0" hits may not be shown on the list. Statistics are generated daily.


text:
Game Dev Tycoon
From Uncyclopedia, the content-free encyclopedia
Game Dev Tycoon is a 2012 video game by Greenheart Games that is not about slaying dragons, rescuing damsels, or eating dots, but about — well, about writing video games. It is a game that only a video-game writer could love. The fact that several video-game players love it too only proves that the world is full of wannabes.
Critics say that a video game by Kairosoft called Game Dev Story was a "creative influence" on Game Dev Tycoon. That would be those too polite to call Game Dev Tycoon an overt rip-off.
Game Dev Tycoon has had a major influence on software development in Silicon Valley.
edit Progression
The game starts in the 1980s in a garage, during the Golden Age of video games. The player has a video terminal connected to CompuServe and must invent an engaging video game about faster-than-light space travel, using nothing but ASCII characters, as he cannot assume the game-buyer owns a graphics card. The player also has some used office furniture. And the garage is where Dad keeps his supply of Schlitz.
The home is a duplex, and the guy in the garage on the other end is Steve Jobs. He seems to be doing something interesting but he's not talking.
edit Advanced stages
As the player gains commercial success, Game Dev Tycoon gives him more advanced challenges. Atari, Sony, and Microsoft bring out new consoles and the player has to "port" his game onto them, even though all the buttons are different, and even though Microsoft has stolen all the features from the previous round and made them standard features of Windows.
If the player is successful at this stage — defined as making $1,000,000, and don't you wish you didn't work at McDonald's in real life? — he will be given a real office in a high-rise "incubator" complex, and will never have to think about whether what he is doing is useful enough to keep paying the rent.
For further successes in the game, the player is given a sexy secretary whose bottom jiggles nicely when you tell her to sharpen all those pencils you are never going to use. And she doesn't mind doing it, because this is a fantasy game.
edit Corporate intrigue
After stealing your ideas and changing Windows so your game no longer runs smoothly, the successful player finds Microsoft waving an absurd amount of money in his face, to buy out the new game company completely. The player is merely asked to stay on as a "consultant."
Gaming blogs say this gambit is a trap. Firstly, the player will not even be able to glance at the bottom of a female fellow employee without risking a trip to Personnel. And he will not be able to develop any new games in the short span of time between off-site coursework on Sensitivity Training. If the player does get a new idea, Management will cancel it when the new game is about 80% done.
edit Winning the game
A gamer who succeeds at all the stages of the game gets to advance to the final stage, where he has a chance to do all of the following:
- Wear a scratchy wool suit.
- Be served the papers for sexual harassment lawsuits, rather than simply risk causing them.
- Receive a meaningless executive title, along with twenty slackers, though it will look good on your business card.
- Testify before the state legislature on risks to the video game industry, such as the mortal risk posed by uncertified inventors working in garages.
edit Impact
The authors of Game Dev Tycoon used a unique method of protecting their game against piracy: They uploaded a deliberately defective version to Torrent. Players pirating this game will be told they suck and will gradually lose money and then lose the game.
At that point, the desperate pirate will run out and pay real money for a clean version, which he will not simply put back on Torrent, least of all with blog posts everywhere about which is the real version and which is the fake.
Although this method was unique when first used, Microsoft has stolen it as well: Every other version of Windows is buggy, crashes frequently, and has gratuitous changes to the user interface (referred to as Genuine Advantage). These customers do not become disgruntled either, but line up to pay again when the good version comes out two years later.


text:
About the Piece
Symphony No. 3 in F major, Op. 90
Last Modified:
Composed: 1883
Length: c. 35 minutes
Orchestration: 2 flutes, 2 oboes, 2 clarinets, 2 bassoons, contrabassoon, 4 horns, 2 trumpets, 3 trombones, timpani, and strings
First Los Angeles Philharmonic performance: February 6, 1920, Walter Henry Rothwell conducting
Although Brahms was just 50 when he wrote his Third Symphony, he looked back to younger days with the musical quotation of the motto Frei aber froh ("Free but happy") which was his defiant response to Joseph Joachim's Frei aber einsam ("Free but lonely"). Brahms would indeed remain single throughout his lifetime, despite a number of infatuations and an especially close relationship with Clara Schumann – both before and after the sad death of her husband Robert at age 46. We know that Brahms wrote the Symphony quickly, in the summer of 1883 in Wiesbaden, working in a rented studio with a view of the Rhine valley. The dramatic aspects of the Third Symphony, the shortest of the four Brahms wrote, are intensified by the compactness of the work.
The F-A-F motif is heard immediately in the rising exclamation from the winds that opens this passionate work. (The second F is actually the first note of the principal theme, which will recur throughout the work, transformed in many ways.) The passion soon subsides to allow for a mood of reflection and nostalgia. This pattern of tension and relaxation continues throughout the movement, and indeed the entire work.
Between the powerful first movement and the similarly charged finale, Brahms nestles two more-relaxed movements, which some claim are based on sketches for an abandoned Faust project from a few years earlier. The Andante, says writer Robert Dearling, "considers the meaning of life and, more than once, seems to dwell in suspended animation while pondering great truths." The ravishing Poco allegretto is an example of the sheer beauty Brahms can create with the simplest of materials and means.
Among the many surprises in this remarkable work is the unusual fact that each of the four movements of the Symphony ends quietly. The mysterious introduction to the finale is followed by a sudden outburst of heroic intensity, but eventually the material from earlier movements is resolved to a shimmering recollection of the opening theme. There is no throbbing tragedy such as that which we encounter in Tchaikovsky's "Pathétique" Symphony, but instead a gentle and comforting serenity.
— Dennis Bade


text:
Best Hospital Rankings: None in PBC
Not one Palm Beach County facility made the rankings of the best hospitals in Florida, as compiled by U.S. News and World Report.
They ranked hospitals across the country and among the state's best, Florida Hospital Orlando was number 1.
You have to make your way to number 7 to find a South Florida hospital...the Bascom Palmer Eye Institute in Miami. There are other hospitals in Broward on the list as well.
The rankings are based on patient survival rates, the quality and efficiency of nurse staffing and the hospital's overall reputation.
Nationwide, the number 1 hospital was the Mayo Clinic in Minnesota.
Click Here to view the full list, then scroll down to see the rankings by region and state, to see the best hospitals in Florida.
Image: Thinkstock


text:
The 51st State
Episode Description
Thanksgiving: exploring food and nutrition with three films: ?Into the Mouths of Babes? by Marc Brugnoni explores the junk food diets of high-school students in Dumont, New Jersey; ?What do the elderly eat?? by Isabella Dane explores the limitations of diet faced by the urban poor; ?Civilization, Whoa!? by Dan Chaykin explores the discoveries of food sources through a block-square working farm in downtown Fair Lawn, New Jersey. Nutritionists Paul A. LaChance and Joan Gussow of Rutgers and Columbia discuss eating habits in a segment titled "After Dinner".
Copyright Holder
Educational Broadcasting Corporation
Colgan, Mick
Executive Producer
Hyatt, Gordon
Kotuk, Richard (as Producer/Reporter)
Chaykin, Dan (as Producer/Reporter)
Ransom, Ted (as Producer/Reporter)
Feiner, Lisa (as Producer/Reporter)
Tuckner, Howard (as Senior Correspondent)
Lachance, Dr. Paul ("After Dinner")
Gussow, Joan ("After Dinner")
Other Credits
Anson, Robert Sam (as Political Correspondent)
Armstrong, Kay (as Location Sound)
Barnard, Aubrey (as Assistant Film Cameras)
Besink, Nick (as Audio)
Blanck, Peter (as Assistant Film Cameras)
Blanck, Peter (as Cameras, ?What the Elderly Eat?)
Caravella, Victor (as Video)
Carucci, Ciro (as Studio Cameras)
Chekmayan, Ara (as Film Editor, ?Teen Age Diet?)Chumbley, Leonard (Technical Director)
Clark, Leslie (?New Jersey Farm?)
Dane, Isabella (Associate Producer)
DiSanto, Guido (as Assistant Film Editor)
Edel, Walter (as Studio Cameras)
Edwards, John (Associate Director)
Foresta, Tony (as Camera, ?Teen Age Diet? and ?New Jersey Farm?)
Gale, David (?Teen Age Diet?)
Gardner, William C. (as Production Assistant)
Garris, Raenelle (Research)
Goldberg, Mark (Production Manager)
Holden, Anton (?New Jersey Farm?)
Hopkins, Jim (as Videotape Editors)
Levey, Charles (as Cameras, ?What the Elderly Eat? and ?New Jersey Farm?)
Nolan, John (Lighting Director)
Orner, Eric (?What the Elderly Eat?)
Ortiz Jr., Eulogio (Associate Producer)
Palmer, Wayne (as Vidifont)
Peaslee, Richard (as Musical Theme)
Pekurney, Paul (as Videotape Editors)
Polizzotto, Frank (as Studio Cameras)
Schaef, Nancy E. K. (as Production Coordinator)
Wax, Robert (as Videotape Editors)
Digital Beta
Reference Number
Program History Scope and Content
Made possible by a grant from the
National Historic Publications and Records Commision (NHPRC)
The 51st State Web site is a production of Thirteen/WNET New York.
©2007 Educational Broadcasting Corporation


text:
The deal covers the $15 billion Pluto project, Browse LNG and the North-West Shelf expansion.
The agreement relates to unlawful industrial action such as wildcat strikes and does not cover legally protected industrial action, which can be undertaken during bargaining over new workplace agreements. Unions agreed to the deal in return for suspended penalties being imposed against individual workers who went on illegal strikes on the Pluto project in late 2009 and early last year.
The deal was revealed during Federal Court proceedings in Perth by construction contractors on the Pluto project taking action against workers in a dispute over the use of portable living quarters.
Lawyers representing individual members of the Construction, Forestry, Mining and Energy Union and the Australian Manufacturing Workers' Union sought an adjournment and reached in-principle agreement. This involves penalties against the individual workers of between $9600 to $11,200 being suspended. More than 1100 workers were involved in the strikes and the suspended fines could total up to $15 million.
The national secretary of the CFMEU's construction division,
"No one is particularly happy about it, but a settlement has been reached and we will stand by our members and will stand by the settlement," he said.
The Australian Building and Construction Commission is a party to the proceedings and Mr Noonan said it was still seeking "punitive action" against the workers, despite the settlement. "You have to question if that's in the public interest," he said.
An ABCC spokesman said the settlement was a matter for the parties but the court might ask for its view on the terms of the deal.
"The ABCC will never stand in the way of a settlement that is within the reasonable bounds of acceptability, having regard to established precedents," he said.
"It is appropriate that the court consider whether a fully suspended sentence in the circumstances of this case falls within that criteria."
The Australian Financial Review


text:
Gift Premium Subscription To cthompson54
Join Date:01-03-2010
Last Activity:06-14-2012 4:06 PM
- East Central Fl Swamp Redneck
- Palm Bay,Florida
- Shooting & Hunting, Gunclub RSO
- Mechanic
Posted in thread: Bobtail 1911 on 08-01-2011 at 12:19 PM
Looking for a gunsmith qualified in the Central Fl area.
Posted in thread: Bobtail 1911 on 08-01-2011 at 02:00 AM
Anyone have experiance with having a 1911 Bobtailed? I've got an early model Kimber Pro Carry
I'm thinking about. Any Ideas? Ct.
Posted in thread: Cross Promotion - ISSC M22 .22LR Giveaway on 11-26-2010 at 12:52 PM
Sign me up, throw me in. Gun club RSO group needs new toys to play with. Nobody has one of
these yet. Thanks, good luck to all. Ct
Posted in thread: For wife...which carry revolver fits? on 09-09-2010 at 02:26 PM
Both my daughters ended up with 3" Model Smiths with larger Crimson Trace laser grips. They
make smaller boot grips but they preferred the larger size. This with that little extra barrel
and weight ma...
Posted in thread: Which 44 magnum snubbie? on 09-08-2010 at 07:51 PM
Could'nt agree more, good revolver to shoot those little 10lb porkers ya'll have out there.
(Just a little Big Texas Humor thats all). Try some of those 300g FNGC for a real blast. I'll
send you some ...
Posted in thread: Which 44 magnum snubbie? on 09-08-2010 at 05:47 PM
I own a 25+ year old 629-1 and a 329. The 629 were called Lew Horton specials back then, mine
was actually listed as a 44 Special on the SW box. Even with short barrel it shoots sweet but
tends to get...
Posted in thread: Concealed Carry on cold range. on 07-29-2010 at 01:26 AM
Simple safety issue question. Should loaded concealed carry pistols be allowed on a "cold
range" with people going down range to inspect targets? What say you everyone? CT.
Posted in thread: New Member Intro. on 04-05-2010 at 03:14 AM
Good evening everyone, my name is Charlie Thompson, aka Tunafish. I live in East Central Fl,
Palm Bay. Been shooting almost 50 years now, presently belong to Pt Malabar Rifle and Pistol
Club for 25 ye...
Posted in thread: Looking for hunting/personal protection gun? on 04-05-2010 at 02:35 AM
We should point out to you Billdogge the dangerous path you may be headed down. Once you start
shooting big bore handguns nothing else will do. Sure 9mm and.357 are nice, but once you touch
off a coup...
Posted in thread: Colt Pony Pocketlite??? on 04-04-2010 at 04:50 AM
The KelTek killer. Sold my P3AT I had for years along with my Sig P230. The little Colt
outshoots them all hands down. Got to say you can't beat the Bersa, just a little bit bigger.
My Mom got the Ber...


text:
After just three rounds, the NRL has already split into the haves and have nots, and the best chance some teams appear to have of making the finals is if players from Cronulla and Manly are suspended for doping violations.
The Bulldogs are the exception. While they are near the bottom of the ladder, the 2012 grand finalists were impressive in last Thursday night's 22-18 loss to premiers Melbourne at AAMI Park and have been playing without key players, while star recruit Tony Williams is yet to fire.
Not only will Canterbury coach Des Hasler welcome star fullback Ben Barba's comeback against South Sydney on Friday, he is also eagerly awaiting the return of forwards Sam Kasiano, Frank Pritchard and James Graham.
Without a halfback to match Cooper Cronk, Johnathan Thurston or even Adam Reynolds, much of the Bulldogs' attack last season revolved around offloads from Kasiano and Graham or left-field shifts in which Pritchard either punched a hole in the defence or ran as a decoy for Barba.
In the end, it took a team of the calibre of Melbourne to stop Hasler's men in the grand final, and the world champions are again the benchmark after impressive wins over Leeds, St George Illawara, North Queensland and Canterbury.
South Sydney are the only other unbeaten team but they weren't totally convincing in wins over Penrith and Cronulla, whose own form raises the question of how good the Sharks could be if they weren't playing under the cloud of a doping scandal that left them without coach Shane Flanagan for the opening two games.
With 14 of their current squad facing drugs bans, the Sharks season is shrouded in uncertainty. Manly are widely believed to have the next highest representation among the 31 NRL players to be interviewed by Australian Sports Anti-Doping Authority investigators - although the club has been cleared of any official involvement.
The Sea Eagles were impressive in their first two matches and Saturday night's 16-14 loss to Gold Coast did more to confirm the Titans' reputation as the premiership's dark horse this season than undermine Manly's credentials.
Like Souths, the Titans have a monstrous side steered around by a rookie playmaker destined for representative honours in Aiden Seizer.
In contrast, Wests Tigers have arguably the smallest forward pack in the NRL, and a massive injury toll. They are also still adapting to the playing style of new coach Michael Potter after a decade under Tim Sheens, but their stars are performing and rookie halfback Jacob Miller shows promise.
Sydney Roosters are in a similar position under Trent Robinson and they showed great resolve in defence last Saturday night to keep the Broncos scoreless. Sonny Bill Williams will keep getting better after returning from his five-year exile only three weeks before the first game.
New Warriors coach Matthew Elliott admitted after Sunday's 28-4 capitulation to Cronulla that the faster play-the-balls in vogue this season should suit his team, but they have been poor so far.
Against the Sharks, the Warriors turned over possession six times on the first or second tackle - including the sets after two Kevin Locke 40:20 kicks and Cronulla's only goal-line drop - and made just three offloads.
In all three matches this season, the Warriors have failed to score a point before halftime and their losing streak now extends to 11 games - suggesting it is not all Elliott's fault and previous coach Brian McLennan wasn't solely to blame either.
St George Illawarra, the only other team yet to win a match this season, are also again struggling to score tries, and Jamie Soward's decision to kick a field goal on Sunday night against Canberra when the Dragons trailed 6-4 highlights their lack of options in attack.
Against Brisbane the week before, St George Illawarra had a mountain of possession on their opponent's tryline but couldn't do anything with it and lost 22-6 in Wollongong.
Justin Hodges was the difference for the Broncos, but without him last Saturday night Brisbane looked as inept in attack as the Dragons had the week before and could not score a point against the Roosters, despite having 54 per cent possession.
Canberra were also held scoreless by Gold Coast in their 36-0 loss last week, and despite beating the Dragons at home on Sunday night one of the most talented rosters in the NRL has again started the season poorly and with question marks over the club's culture.
Penrith and Parramatta have shown some signs of promise but both clubs are rebuilding and officials admit neither the Panthers or Eels expect to be a competitive force this season.


text:
This paper will demonstrate how Aztech has fine-tuned its presentation of assistive technology presentations to manufacturers for potential sale or license using our feedback from a marketing survey. It will show what information is most valuable to the manufacturer in making new product decisions. Aztech, in collaboration with The RERC on Technology and Evaluation and Transfer, solicits assistive devices from inventors for commercial evaluation. For devices that meet a significant unmet need in the marketplace, we seek to license the device to a manufacturer who will bring it to market. The information is packaged in a way to satisfy the needs of the manufacturers and expedite the new product evaluation process.
[ Top of Page ]


text:
Assessment |
Biopsychology |
Comparative |
Cognitive |
Developmental |
Language |
Individual differences |
Personality |
Philosophy |
Social |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |
Professional Psychology: Debating Chamber · Psychology Journals · Psychologists
Digital asset management (DAM) refers to the practice and domain of organizing digital files, like images, documents, videos and presentations. The term asset is used to indicate that such files have some sort of intrinsic value that makes it worthwhile to manage them. DAM is related to and can be considered a superset of content management. For more information see also digital asset management systems and content management systems.
External linksEdit
- Article "Intro to Digital Asset Management: Just what is a DAM?" by Magan Arthur
- Article "What is Digital Asset Management?"
- The DAM User Community & Home to the DAM Symposium
- Links from EContent
- Cost savings from DAM
- Introduction to Digital Asset Management
|This page uses Creative Commons Licensed content from Wikipedia (view authors).


text:
Tips for Safe Holiday Fireworks Use
The West Virginia State Fire Marshall's office is reminding everyone that any type of firework-type material is dangerous.
Even sparklers can burn hot enough to cause third degree burns.
If you do use sparklers and novelities this holiday use extreme caution; before using any legal fireworks read and follow all warning instructions.
Light all items outside in a clear area away from homes and yard debris.
Always keep a bucket of water nearby for emergencies and to douse items that fail to ignite.
Never ignite fireworks in a container and teach your children to never touch unexploded fireworks.
Fireworks permissible in West Virginia include snakes, glo-worms, smoke devices, party poppers, snappers, drop pops, string poppers wire sparklers and other sparkling devices that emit showers of sparks and sometimes a whistling effect or crackling effect while burning.


text:
Welcome to the community week review, posted by Nuno Linhares. This is a weekly update of whats happening with the SDL Tridion community so don't have to miss a single message.
Welcome to our weekly recap of #SDLTridion community activity, again with a great selection of the content being created out there by our partners & colleagues.
Welcome to the latest community review, in a week full of good discussions � mostly about the soon to be released SDL Tridion UI and workflow and the rumors about Tridion workflow being re-invented (which is capturing quite a lot of attention judging by the posts by Chris Summers and Robert Curlette).
Hi and welcome to one more weekly review, for the week ending on March 18th.
Welcome to our weekly community review, full of goodies from last week's blog production. What a week we had (check out the statistics) with loads of positive feedback regarding SDL Innovate and great content � again.
Hello all and welcome to one more review of our community's activity.
Welcome to our weekly review of Community Activity for the week ending on February 26th.
Welcome to our community review for the week ending February 19th.
And once again, welcome to our weekly SDL Tridion Community review for the week ending on February 12th 2012. This one has a special feel to it, as we reach our 26th edition � or approximately half a year of weekly reviews.
Welcome to our Weekly community review for February 5th 2012.
This week was obviously dominated by the Alterian acquisition news, and how the integration of the various businesses and operations will develop in the next few months. But of course it didn't stop there. This week we have again a great selection of high-value content, including samples on using the Razor Mediator, Nuno feeling for editors and automating Tridion tasks.
And here's our weekly review, on what's been the busiest week so far this year! There is plenty of good content to read on this week's summary.
Hi everyone, and welcome to our weekly community activity review for January 22nd.
The biggest event of this week was Saturday's announcement of the SDL Tridion MVPs for 2012, our 3rd year in a row with this program that has undoubtedly helped create a wider and deeper sense of a Technical Community for SDL Tridion technical resources around the world.
Hi everyone, and welcome to our latest community week review. We had again a great week, with loads of good information being published, and � of course � we had our 2nd SDL Tridion Community Webinar � the biggest ever, with 50% more participants than the previous one.
In this edition of our newsletter we will cover 2 weeks after our end-of-year break.
Welcome to the 2011 archive of the community week review, posted by Nuno Linhares.
Download free template building blocks!
© SDL Tridion. All rights reserved